Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses

Post-exposure vaccination with vaccinia virus (VACV) has been suggested to be effective in minimizing death if administered within four days of smallpox exposure. While there is anecdotal evidence for efficacy of post-exposure vaccination this has not been definitively studied in humans. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Holechek, Susan A., Denzler, Karen L., Heck, Michael C., Schriewer, Jill, Buller, R. Mark, Legrand, Fatema A., Verardi, Paulo H., Jones, Leslie A., Yilma, Tilahun, Jacobs, Bertram L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798613/
https://www.ncbi.nlm.nih.gov/pubmed/24147092
http://dx.doi.org/10.1371/journal.pone.0077879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798613/
https://www.ncbi.nlm.nih.gov/pubmed/24147092
http://dx.doi.org/10.1371/journal.pone.0077879

Ejemplares similares